{"id":800382,"date":"2026-03-03T03:46:23","date_gmt":"2026-03-03T03:46:23","guid":{"rendered":"https:\/\/www.europesays.com\/uk\/800382\/"},"modified":"2026-03-03T03:46:23","modified_gmt":"2026-03-03T03:46:23","slug":"bristol-myers-squibb-announces-dividend","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/uk\/800382\/","title":{"rendered":"Bristol Myers Squibb Announces Dividend"},"content":{"rendered":"<p>    <img fetchpriority=\"high\" decoding=\"async\" src=\"https:\/\/www.europesays.com\/uk\/wp-content\/uploads\/2026\/03\/4cced493088d69cc55c06ba849125932.jpeg\" alt=\"\" loading=\"eager\" height=\"132\" width=\"960\" class=\"yf-lglytj  loaded\"\/>     <\/p>\n<p class=\"yf-1fy9kyt\"><b>PRINCETON, N.J., March 02, 2026<\/b>&#8211;(<a href=\"https:\/\/www.businesswire.com\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:BUSINESS WIRE;elm:context_link;itc:0;sec:content-canvas\" class=\"link \">BUSINESS WIRE<\/a>)&#8211;<a href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.bms.com%2F&amp;esheet=54436693&amp;newsitemid=20260302267205&amp;lan=en-US&amp;anchor=Bristol+Myers+Squibb&amp;index=1&amp;md5=460b6ea9a2cbc9e81cb7bf0c4c51013b\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:Bristol Myers Squibb;elm:context_link;itc:0;sec:content-canvas\" class=\"link \">Bristol Myers Squibb<\/a> (NYSE: BMY) today announced that its Board of Directors has declared a quarterly dividend of sixty-three cents ($0.63) per share on the $0.10 par value common stock of the company.<\/p>\n<p class=\"yf-1fy9kyt\">The dividend is payable on May 1, 2026, to stockholders of record at the close of business on April 2, 2026.<\/p>\n<p class=\"yf-1fy9kyt\"><b>About Bristol Myers Squibb: Transforming Patients\u2019 Lives Through Science<\/b><\/p>\n<p class=\"yf-1fy9kyt\">At Bristol Myers Squibb, our mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases. We are pursuing bold science to define what\u2019s possible for the future of medicine and the patients we serve. For more information about Bristol Myers Squibb, visit us at <a href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.bms.com&amp;esheet=54436693&amp;newsitemid=20260302267205&amp;lan=en-US&amp;anchor=BMS.com&amp;index=2&amp;md5=5b3315428306149bee9f7c3552dd6919\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:BMS.com;elm:context_link;itc:0;sec:content-canvas\" class=\"link \">BMS.com<\/a> and follow us on <a href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2F1773%3Ftrk%3Dtyah%26trkInfo%3DclickedVertical%253Acompany%252CclickedEntityId%253A1773%252Cidx%253A2-1-2%252CtarId%253A1462816198861%252Ctas%253Abristol-&amp;esheet=54436693&amp;newsitemid=20260302267205&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=3&amp;md5=f05b3033634236b2c6d2f484027e3c3a\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:LinkedIn;elm:context_link;itc:0;sec:content-canvas\" class=\"link \">LinkedIn<\/a>, <a href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2Fbmsnews&amp;esheet=54436693&amp;newsitemid=20260302267205&amp;lan=en-US&amp;anchor=X&amp;index=4&amp;md5=741c9dcf966c55919de510b172b550da\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:X;elm:context_link;itc:0;sec:content-canvas\" class=\"link \">X<\/a>, <a href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.youtube.com%2Fchannel%2FUCjFf4oKibYrHae2NZ_GPS6g&amp;esheet=54436693&amp;newsitemid=20260302267205&amp;lan=en-US&amp;anchor=YouTube&amp;index=5&amp;md5=9d43413f5ae8c9bbe0ecdc1d2e6c07d9\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:YouTube;elm:context_link;itc:0;sec:content-canvas\" class=\"link \">YouTube<\/a>, <a href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.facebook.com%2Fbristolmyerssquibb&amp;esheet=54436693&amp;newsitemid=20260302267205&amp;lan=en-US&amp;anchor=Facebook&amp;index=6&amp;md5=6ae2be0b234ca6a6d2378a0ece7a1849\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:Facebook;elm:context_link;itc:0;sec:content-canvas\" class=\"link \">Facebook<\/a>, and <a href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.instagram.com%2Fbristolmyerssquibb%2F&amp;esheet=54436693&amp;newsitemid=20260302267205&amp;lan=en-US&amp;anchor=Instagram&amp;index=7&amp;md5=a8518e1ce730ff439d61a3017f4dc698\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:Instagram;elm:context_link;itc:0;sec:content-canvas\" class=\"link \">Instagram<\/a>.<\/p>\n<p class=\"yf-1fy9kyt\">corporatefinancial-news<\/p>\n<p class=\"yf-1fy9kyt\">View source version on businesswire.com: <a href=\"https:\/\/www.businesswire.com\/news\/home\/20260302267205\/en\/\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:https:\/\/www.businesswire.com\/news\/home\/20260302267205\/en\/;elm:context_link;itc:0;sec:content-canvas\" class=\"link \">https:\/\/www.businesswire.com\/news\/home\/20260302267205\/en\/<\/a><\/p>\n<p class=\"yf-1fy9kyt\"><b>Contacts<\/b><\/p>\n<p class=\"yf-1fy9kyt\"><b>Media Relations: <\/b><br \/><a href=\"https:\/\/finance.yahoo.com\/news\/mailto:media@bms.com\" rel=\"nofollow noopener\" data-ylk=\"slk:media@bms.com;elm:context_link;itc:0;sec:content-canvas\" class=\"link \" target=\"_blank\">media@bms.com<\/a><\/p>\n<p class=\"yf-1fy9kyt\"><b>Investor Relations: <\/b><br \/><a href=\"https:\/\/finance.yahoo.com\/news\/mailto:investor.relations@bms.com\" rel=\"nofollow noopener\" data-ylk=\"slk:investor.relations@bms.com;elm:context_link;itc:0;sec:content-canvas\" class=\"link \" target=\"_blank\">investor.relations@bms.com<\/a><\/p>\n<p>   <script async src=\"https:\/\/platform.twitter.com\/widgets.js\" charset=\"utf-8\"><\/script><script async src=\"\/\/www.instagram.com\/embed.js\"><\/script><\/p>\n","protected":false},"excerpt":{"rendered":"PRINCETON, N.J., March 02, 2026&#8211;(BUSINESS WIRE)&#8211;Bristol Myers Squibb (NYSE: BMY) today announced that its Board of Directors has&hellip;\n","protected":false},"author":2,"featured_media":800383,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[8818],"tags":[381,23890,748,165127,393,4884,232066,16,15],"class_list":["post-800382","post","type-post","status-publish","format-standard","has-post-thumbnail","category-bristol","tag-bristol","tag-bristol-myers-squibb","tag-britain","tag-business-wire","tag-england","tag-great-britain","tag-quarterly-dividend","tag-uk","tag-united-kingdom"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@uk\/116163194762724666","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/800382","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/comments?post=800382"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/800382\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media\/800383"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media?parent=800382"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/categories?post=800382"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/tags?post=800382"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}